Strongyloidiasis is a disease caused by Strongyloides stercoralis and remains a neglected
tropical infection despite significant public health concerns. Challenges in the management …

Introduction Many immunomodulators have been studied in clinical trials for the treatment of
coronavirus disease 2019 (COVID-19). However, data identifying the most effective and …

Strongyloides stercoralis is one of the common parasites in tropical areas. It can result in
severe clinical syndromes, hyperinfection syndrome or disseminated strongyloidiasis in …

Background Molnupiravir and ritonavir-boosted nirmatrelvir are the two leading oral COVID-19
antiviral treatments, but their antiviral activities in patients have not been compared …

Strongyloides hyperinfection syndrome and disseminated strongyloidiasis frequently occur
in immunocompromised persons and can lead to high complication and mortality rates. Thus, …

Acute undifferentiated febrile illness (AUFI) has been a diagnostic dilemma in the tropics.
Without accurate point-of-care tests, information on local pathogens and clinical parameters is …

We report a 50-year-old Thai woman with recent travel to Denmark who presented with
acute high-grade fever, vomiting, and myalgia for 1 day. Initial laboratory results revealed …

Background Uncertainty over the therapeutic benefit of parenteral remdesivir in coronavirus
disease 2019 (COVID-19) has resulted in varying treatment guidelines. Methods In a …

Brief summary In early symptomatic COVID-19 treatment, high dose oral favipiravir did not
accelerate viral clearance. Background Favipiravir, an anti-influenza drug, has in vitro antiviral …

Differentiating dengue patients from other acute febrile illness patients is a great challenge
among physicians. Several dengue diagnosis methods are recommended by WHO. The …